Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Intraepithelial Lesions 4Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 2Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1Papillomavirus Infections 1Head and Neck Squamous Cell Cancer 1HIV Seropositivity 1Anus Neoplasms 1

Interventions

Cetuximab 2Alpelisib 2rocakinogene sifuplasmid 1cabozantinib 1VGX-3100 1Radiotherapy, Intensity-Modulated 1Metformin 1MEDI0457 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Head and Neck Squamous Cell Cancer × VGX-3100 × Clear all
NCT02163057 2021-01-22

Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma

Inovio Pharmaceuticals

Phase 1/2 Completed
22 enrolled 14 charts
Head & Neck

Head and Neck Squamous Cell Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡